Release 4B

This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

4.3.14.493 Code System http://hl7.org/fhir/substance-name-authority

Biomedical Research and Regulation Work Group Maturity Level: 1Trial Use Use Context: Any

This is a code system defined by the FHIR project.

Summary

Defining URL:http://hl7.org/fhir/substance-name-authority
Version:4.3.0
Name:SubstanceNameAuthority
Title:SubstanceNameAuthority
Definition:
Committee:Biomedical Research and Regulation Work Group
OID:2.16.840.1.113883.4.642.1.1637 (for OID based terminology systems)
Source ResourceXML / JSON

This Code system is used in the following value sets:

4.3.14.493.1 Content

This code system http://hl7.org/fhir/substance-name-authority defines the following codes:

CodeDisplay
BAN BAN
COSING COSING
Ph.Eur. Ph.Eur.
FCC FCC
INCI INCI
INN INN
JAN JAN
JECFA JECFA
MARTINDALE MARTINDALE
USAN USAN
USP USP
PHF PHF
HAB HAB
PhF PhF (Pharmacopée française)
IUIS IUIS

 

See the full registry of code systems defined as part of FHIR.

Explanation of the columns that may appear on this page:

LevelA few code lists that FHIR defines are hierarchical - each code is assigned a level. See Code System for further information.
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code